![FibroGen Inc](/common/images/company/N_FGEN.png)
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated... FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0499 | 9.97800439912 | 0.5001 | 0.55 | 0.455 | 541143 | 0.49282998 | CS |
4 | -0.012 | -2.13523131673 | 0.562 | 0.61 | 0.45 | 711746 | 0.50464638 | CS |
12 | 0.1628 | 42.0454545455 | 0.3872 | 0.755 | 0.311 | 1114235 | 0.49520254 | CS |
26 | 0.17 | 44.7368421053 | 0.38 | 0.755 | 0.18 | 1170390 | 0.41761713 | CS |
52 | -1.67 | -75.2252252252 | 2.22 | 2.8 | 0.18 | 1798112 | 0.9833865 | CS |
156 | -15.07 | -96.4788732394 | 15.62 | 25.69 | 0.18 | 1780728 | 4.41001714 | CS |
260 | -44.15 | -98.7695749441 | 44.7 | 57.2088 | 0.18 | 1471043 | 10.50726282 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales